US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 25.630
  • +0.130+0.51%
Close Dec 23 16:00 ET
  • 25.900
  • +0.270+1.05%
Post 16:05 ET
2.68BMarket Cap-11.60P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
73.39%-12.5M
-84.20%-53.98M
-71.36%-54.6M
-1,424.13%-141.22M
-33.07M
-46.98M
-29.31M
-31.86M
136.14%10.67M
-301.92%-29.51M
Net income from continuing operations
64.68%-16.65M
-1.87%-39.01M
-123.16%-93.77M
-681.73%-176.94M
---49.5M
---47.13M
---38.29M
---42.02M
45.83%-22.63M
-490.94%-41.79M
Operating gains losses
-717.03%-3.91M
-2,161.14%-8.7M
1,231.02%41.37M
-51.56%5.23M
--1.06M
--634K
--422K
--3.11M
1,410.81%10.79M
-2,688.05%-823K
Depreciation and amortization
100.00%28K
46.15%19K
66.67%15K
444.44%49K
--13K
--14K
--13K
--9K
80.00%9K
306.52%5K
Other non cash items
150.00%5K
100.00%2K
-50.00%1K
-99.93%6K
--1K
--2K
--1K
--2K
8.61%8.01M
1,717.51%7.38M
Change In working capital
100.48%28K
-587.47%-14.59M
-1,647.76%-10.14M
-43.45%5.87M
--9.34M
---5.89M
--2.99M
---580K
132.06%10.37M
788.31%4.47M
-Change in prepaid assets
83.84%-493K
-269.36%-9.23M
167.66%956K
196.32%4.03M
--3.04M
---3.05M
--5.45M
---1.41M
20.01%-4.19M
-213.47%-5.23M
-Change in payables and accrued expense
2,056.07%2.31M
-314.29%-3.07M
-337.72%-9.69M
372.35%10.54M
--7.1M
--107K
---742K
--4.08M
-139.89%-3.87M
851.52%9.7M
-Change in other working capital
39.29%-1.79M
-32.73%-2.28M
56.81%-1.4M
-147.24%-8.71M
---802K
---2.94M
---1.72M
---3.24M
--18.43M
----
Cash from discontinued investing activities
Operating cash flow
73.39%-12.5M
-84.20%-53.98M
-71.36%-54.6M
-1,424.13%-141.22M
---33.07M
---46.98M
---29.31M
---31.86M
136.14%10.67M
-301.92%-29.51M
Investing cash flow
Cash flow from continuing investing activities
-733.33%-75K
-4,080.00%-209K
-5,400.00%-385K
89.14%-24K
-3K
-9K
-5K
-7K
-820.83%-221K
-50.10%-24K
Net PPE purchase and sale
-733.33%-75K
-4,080.00%-209K
-5,400.00%-385K
89.14%-24K
---3K
---9K
---5K
---7K
-820.83%-221K
-50.10%-24K
Cash from discontinued investing activities
Investing cash flow
-733.33%-75K
-4,080.00%-209K
-5,400.00%-385K
89.14%-24K
---3K
---9K
---5K
---7K
-820.83%-221K
-50.10%-24K
Financing cash flow
Cash flow from continuing financing activities
-68.82%58K
-26.46%4.66M
8,185.12%198.18M
-97.73%8.91M
0
186K
6.33M
2.39M
362.68%391.91M
508.37%84.7M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--747K
--0
Net common stock issuance
--0
--0
--190.48M
--0
--0
--0
--0
--0
368.63%396.95M
--84.7M
Proceeds from stock option exercised by employees
-68.82%58K
-26.46%4.66M
284.74%9.2M
--8.91M
--0
--186K
--6.33M
--2.39M
--0
--0
Net other financing activities
--0
--0
---1.5M
----
----
----
----
----
---5.79M
----
Cash from discontinued financing activities
Financing cash flow
-68.82%58K
-26.46%4.66M
8,185.12%198.18M
-97.73%8.91M
--0
--186K
--6.33M
--2.39M
362.68%391.91M
508.37%84.7M
Net cash flow
Beginning cash position
3.36%430.71M
9.03%481.15M
-27.21%340.45M
677.85%467.73M
--368.31M
--416.71M
--441.31M
--467.73M
523.38%60.13M
213.70%9.65M
Current changes in cash
73.25%-12.52M
-115.57%-49.53M
585.76%143.19M
-132.89%-132.33M
---33.08M
---46.8M
---22.98M
---29.48M
629.32%402.35M
740.43%55.17M
Effect of exchange rate changes
383.75%4.54M
44.23%-909K
-181.52%-2.5M
-3.73%5.05M
--5.22M
---1.6M
---1.63M
--3.06M
212.06%5.25M
-15,964.44%-4.68M
End cash Position
14.78%422.73M
3.36%430.71M
9.03%481.15M
-27.21%340.45M
--340.45M
--368.31M
--416.71M
--441.31M
677.85%467.73M
521.92%60.13M
Free cash flow
73.23%-12.58M
-84.88%-54.19M
-72.54%-54.99M
-1,452.37%-141.24M
---33.08M
---46.99M
---29.31M
---31.87M
135.36%10.44M
-301.37%-29.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 73.39%-12.5M-84.20%-53.98M-71.36%-54.6M-1,424.13%-141.22M-33.07M-46.98M-29.31M-31.86M136.14%10.67M-301.92%-29.51M
Net income from continuing operations 64.68%-16.65M-1.87%-39.01M-123.16%-93.77M-681.73%-176.94M---49.5M---47.13M---38.29M---42.02M45.83%-22.63M-490.94%-41.79M
Operating gains losses -717.03%-3.91M-2,161.14%-8.7M1,231.02%41.37M-51.56%5.23M--1.06M--634K--422K--3.11M1,410.81%10.79M-2,688.05%-823K
Depreciation and amortization 100.00%28K46.15%19K66.67%15K444.44%49K--13K--14K--13K--9K80.00%9K306.52%5K
Other non cash items 150.00%5K100.00%2K-50.00%1K-99.93%6K--1K--2K--1K--2K8.61%8.01M1,717.51%7.38M
Change In working capital 100.48%28K-587.47%-14.59M-1,647.76%-10.14M-43.45%5.87M--9.34M---5.89M--2.99M---580K132.06%10.37M788.31%4.47M
-Change in prepaid assets 83.84%-493K-269.36%-9.23M167.66%956K196.32%4.03M--3.04M---3.05M--5.45M---1.41M20.01%-4.19M-213.47%-5.23M
-Change in payables and accrued expense 2,056.07%2.31M-314.29%-3.07M-337.72%-9.69M372.35%10.54M--7.1M--107K---742K--4.08M-139.89%-3.87M851.52%9.7M
-Change in other working capital 39.29%-1.79M-32.73%-2.28M56.81%-1.4M-147.24%-8.71M---802K---2.94M---1.72M---3.24M--18.43M----
Cash from discontinued investing activities
Operating cash flow 73.39%-12.5M-84.20%-53.98M-71.36%-54.6M-1,424.13%-141.22M---33.07M---46.98M---29.31M---31.86M136.14%10.67M-301.92%-29.51M
Investing cash flow
Cash flow from continuing investing activities -733.33%-75K-4,080.00%-209K-5,400.00%-385K89.14%-24K-3K-9K-5K-7K-820.83%-221K-50.10%-24K
Net PPE purchase and sale -733.33%-75K-4,080.00%-209K-5,400.00%-385K89.14%-24K---3K---9K---5K---7K-820.83%-221K-50.10%-24K
Cash from discontinued investing activities
Investing cash flow -733.33%-75K-4,080.00%-209K-5,400.00%-385K89.14%-24K---3K---9K---5K---7K-820.83%-221K-50.10%-24K
Financing cash flow
Cash flow from continuing financing activities -68.82%58K-26.46%4.66M8,185.12%198.18M-97.73%8.91M0186K6.33M2.39M362.68%391.91M508.37%84.7M
Net issuance payments of debt --------------0------------------747K--0
Net common stock issuance --0--0--190.48M--0--0--0--0--0368.63%396.95M--84.7M
Proceeds from stock option exercised by employees -68.82%58K-26.46%4.66M284.74%9.2M--8.91M--0--186K--6.33M--2.39M--0--0
Net other financing activities --0--0---1.5M-----------------------5.79M----
Cash from discontinued financing activities
Financing cash flow -68.82%58K-26.46%4.66M8,185.12%198.18M-97.73%8.91M--0--186K--6.33M--2.39M362.68%391.91M508.37%84.7M
Net cash flow
Beginning cash position 3.36%430.71M9.03%481.15M-27.21%340.45M677.85%467.73M--368.31M--416.71M--441.31M--467.73M523.38%60.13M213.70%9.65M
Current changes in cash 73.25%-12.52M-115.57%-49.53M585.76%143.19M-132.89%-132.33M---33.08M---46.8M---22.98M---29.48M629.32%402.35M740.43%55.17M
Effect of exchange rate changes 383.75%4.54M44.23%-909K-181.52%-2.5M-3.73%5.05M--5.22M---1.6M---1.63M--3.06M212.06%5.25M-15,964.44%-4.68M
End cash Position 14.78%422.73M3.36%430.71M9.03%481.15M-27.21%340.45M--340.45M--368.31M--416.71M--441.31M677.85%467.73M521.92%60.13M
Free cash flow 73.23%-12.58M-84.88%-54.19M-72.54%-54.99M-1,452.37%-141.24M---33.08M---46.99M---29.31M---31.87M135.36%10.44M-301.37%-29.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data